Barclays
MED icon

Barclays’s Medifast MED Stock Holding History

Barclays’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,600
Closed -$100K – 5983
2020
Q1 		$100K Sell
1,600
-14,600
-90% -$1.33M ﹤0.01% 4801
2019
Q4 		$1.77M Buy
16,200
+1,600
+11% +$155K ﹤0.01% 3136
2019
Q3 		$1.51M Sell
14,600
-32,400
-69% -$3.48M ﹤0.01% 3214
2019
Q2 		$6.03M Buy
47,000
+44,200
+1,579% +$6.14M ﹤0.01% 1702
2019
Q1 		$357K Sell
2,800
-400
-13% -$50.7K ﹤0.01% 4385
2018
Q4 		$400K Buy
3,200
+2,100
+191% +$359K ﹤0.01% 4011
2018
Q3 		$244K Sell
1,100
-2,100
-66% -$426K ﹤0.01% 4846
2018
Q2 		$513K Buy
3,200
+2,600
+433% +$332K ﹤0.01% 3929
2018
Q1 		$56K Sell
600
-700
-54% -$52.3K ﹤0.01% 5829
2017
Q4 		$91K Sell
1,300
-1,300
-50% -$86.2K ﹤0.01% 5314
2017
Q3 		$154K Buy
+2,600
New +$129K ﹤0.01% 4626
2017
Q1 		– Sell
-100
Closed -$4K – 6889
2016
Q4 		$4K Buy
+100
New +$4.03K ﹤0.01% 6194
2015
Q3 		– Sell
-100
Closed -$3K – 6955
2015
Q2 		$3K Buy
+100
New +$3.17K ﹤0.01% 6684
2015
Q1 		– Sell
-100
Closed -$3K – 7176
2014
Q4 		$3K Sell
100
-1,600
-94% -$49.8K ﹤0.01% 7063
2014
Q3 		$54K Hold
1,700
– – ﹤0.01% 5820
2014
Q2 		$51K Sell
1,700
-3,500
-67% -$109K ﹤0.01% 5926
2014
Q1 		$151K Buy
5,200
+3,600
+225% +$96.4K ﹤0.01% 5059
2013
Q4 		$41K Sell
1,600
-700
-30% -$17.9K ﹤0.01% 6316
2013
Q3 		$60K Sell
2,300
-800
-26% -$21.4K ﹤0.01% 5959
2013
Q2 		$80K Buy
+3,100
New +$81.4K ﹤0.01% 5975

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Barclays's MED Position: Q1 2026 in Review

Barclays reduced its Medifast (MED) stake by 89% in Q1 2026, selling an estimated $160K and leaving 1,926 shares worth $19.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4581.

Barclays first reported a position in MED in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.69M in Q1 2021. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Barclays held 1,926 shares of Medifast worth $19.6K as of Q1 2026.
  • Barclays sold 14,843 Medifast shares in Q1 2026, an estimated $160K.
  • Medifast made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4581 holding.
  • Barclays first reported a position in Medifast in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Medifast position peaked at $3.69M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.